Clinical Trial Update: Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis

View source ↗

Summary

A real-world effectiveness study evaluating long-term dupilumab use in participants aged 6 years and older with atopic dermatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis | Status: RECRUITING